# Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy

> **NCT06482333** · NA · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 194 (estimated)

## Conditions studied

- Postpolypectomy Bleeding

## Interventions

- **OTHER:** Time for resumption of DOAC

## Key facts

- **NCT ID:** NCT06482333
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-03
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482333, "Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06482333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*